Advances in pediatric pharmacology and toxicology.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001682:Biological Availability; D002648:Child; D002675:Child, Preschool; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007700:Kinetics; D008431:Maternal-Fetal Exchange; D008787:Metoclopramide / Q000627:therapeutic use; D010033:Otitis Media / Q000188:drug therapy; D010034:Otitis Media with Effusion / Q000188:drug therapy; D010372:Pediatrics; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010600:Pharmacology; D010634:Phenobarbital / Q000627:therapeutic use; D011247:Pregnancy; D012202:Reye Syndrome / Q000139:chemically induced; D012455:Salamandridae; D012640:Seizures / Q000188:drug therapy; D005879:Tourette Syndrome / Q000188:drug therapy; D014116:Toxicology; D014635:Valproic Acid / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004364:Pharmaceutical Preparations; D014635:Valproic Acid; D008787:Metoclopramide; D001241:Aspirin; D010634:Phenobarbital